Literature DB >> 33385354

Relation of Bariatric Surgery to Inpatient Cardiovascular Outcomes (from the National Inpatient Sample).

Tran Nguyen1, Talal Alzahrani1, Ari Mandler1, Mohammad Alarfaj1, Gurusher Panjrath1, Joseph Krepp2.   

Abstract

Approximately one in 3 patients in the United States are obese. There is a strong association between obesity and an increased rate of cardiovascular disease (CVD)-related mortality. Bariatric surgery (BS) has emerged as an effective strategy to achieve reduction of excess weight. Our study aims to explore the relationship between BS and major adverse cardiovascular events (MACE) among obese hospitalized patients in the United States. This is a retrospective study of all obese adult patients with BMI ≥35 kg/m2 (n= 1,700,943) in the National Inpatient Sample between 2012 and 2016. Differences in the clinical characteristics of obese patients with a history of BS versus obese patients without a history of BS were analyzed as well as the association between BS and MACE after adjusting for CVD risk factors. Among 50,296 obese patients with a history of BS (2.96%), the mean age was 53 ± 12 years with the majority being female (75.32%) and Caucasian (71.85%). Multivariate analysis revealed that obese patients with a history of BS had a1.6-fold decrease odds of MACE compared with patients without BS (OR 0.62; 95% CI, 0.60 to 0.65; p <0.001). In conclusion, this study illustrates that among obese patients with BMI ≥35 kg/m2, history of BS was associated with a significantly lower odds of inpatient MACE, after adjusting for CVD risk factors.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 33385354     DOI: 10.1016/j.amjcard.2020.12.049

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  1 in total

1.  Association between cardiovascular health metrics and risk of incident type 2 diabetes mellitus: the Rural Chinese Cohort Study.

Authors:  Pei Qin; Dechen Liu; Yifei Feng; Xingjin Yang; Yang Li; Yuying Wu; Huifang Hu; Jinli Zhang; Tianze Li; Xi Li; Yang Zhao; Chuanqi Chen; Fulan Hu; Ming Zhang; Yu Liu; Xizhuo Sun; Dongsheng Hu
Journal:  Acta Diabetol       Date:  2022-05-28       Impact factor: 4.280

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.